After J.P. Morgan and Ladenburg Thalmann & Co. gave United Therapeutics (NASDAQ: UTHR) a Buy rating last month, the company received another Buy, this time from Jefferies. Analyst Eun Yang maintained a Buy rating on United Therapeutics today and set a price target of $223.00. The company’s shares closed last Wednesday at $175.35.
According to TipRanks.com, Yang is a 4-star analyst with an average return of 4.6% and a 47.5% success rate. Yang covers the Healthcare sector, focusing on stocks such as Taysha Gene Therapies, Blueprint Medicines, and Keros Therapeutics.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for United Therapeutics with a $235.83 average price target, implying a 41.6% upside from current levels. In a report issued on February 25, Ladenburg Thalmann & Co. also maintained a Buy rating on the stock with a $203.00 price target.
United Therapeutics’ market cap is currently $7.91B and has a P/E ratio of 17.49.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.
Read More on UTHR:
- Analysts’ Top Technology Picks: Microchip (MCHP), Spirit AeroSystems (SPR)
- Wall Street Analysts Are Bullish on Top Consumer Goods Picks
- American Eagle Outfitters Expects Earnings Decline; Shares Drop 5.3%
- Seanergy Maritime (SHIP) Receives a Rating Update from a Top Analyst
- Analysts Offer Insights on Conglomerates Companies: Orion Group Holdings (ORN) and Workhorse Group (WKHS)